USD 2.34
(0.86%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 2.28 Million USD | 203.59% |
2022 | 752 Thousand USD | -55.63% |
2021 | 1.69 Million USD | 172.07% |
2020 | 623 Thousand USD | 17.55% |
2019 | 530 Thousand USD | 66.67% |
2018 | 318 Thousand USD | 33.05% |
2017 | 239 Thousand USD | 4.37% |
2016 | 229 Thousand USD | 55.78% |
2015 | 147 Thousand USD | -27.59% |
2014 | 203 Thousand USD | -3.79% |
2013 | 211 Thousand USD | 27.11% |
2012 | 166 Thousand USD | 76.6% |
2011 | 94 Thousand USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 817 Thousand USD | -11.29% |
2024 Q1 | 921 Thousand USD | -21.75% |
2023 Q2 | 294 Thousand USD | -16.95% |
2023 Q1 | 354 Thousand USD | 447.06% |
2023 Q3 | 458 Thousand USD | 55.78% |
2023 Q4 | 1.17 Million USD | 156.99% |
2023 FY | 2.28 Million USD | 203.59% |
2022 Q1 | 272 Thousand USD | -64.9% |
2022 Q2 | 485 Thousand USD | 78.31% |
2022 Q3 | 97 Thousand USD | -80.0% |
2022 Q4 | -102 Thousand USD | -205.15% |
2022 FY | 752 Thousand USD | -55.63% |
2021 Q1 | 103 Thousand USD | 14.44% |
2021 Q3 | 499 Thousand USD | 56.92% |
2021 Q4 | 775 Thousand USD | 55.31% |
2021 Q2 | 318 Thousand USD | 208.74% |
2021 FY | 1.69 Million USD | 172.07% |
2020 Q4 | 90 Thousand USD | -40.0% |
2020 Q2 | 269 Thousand USD | 135.96% |
2020 FY | 623 Thousand USD | 17.55% |
2020 Q1 | 114 Thousand USD | 31.03% |
2020 Q3 | 150 Thousand USD | -44.24% |
2019 Q1 | 79 Thousand USD | 46.3% |
2019 FY | 530 Thousand USD | 66.67% |
2019 Q4 | 87 Thousand USD | -13.86% |
2019 Q3 | 101 Thousand USD | -61.6% |
2019 Q2 | 263 Thousand USD | 232.91% |
2018 Q3 | 54 Thousand USD | -59.09% |
2018 FY | 318 Thousand USD | 33.05% |
2018 Q1 | 77 Thousand USD | 10.0% |
2018 Q2 | 132 Thousand USD | 71.43% |
2018 Q4 | 54 Thousand USD | 0.0% |
2017 FY | 239 Thousand USD | 4.37% |
2017 Q1 | 52 Thousand USD | 6.12% |
2017 Q2 | 52 Thousand USD | 0.0% |
2017 Q3 | 65 Thousand USD | 25.0% |
2017 Q4 | 70 Thousand USD | 7.69% |
2016 Q1 | 57 Thousand USD | 46.15% |
2016 FY | 229 Thousand USD | 55.78% |
2016 Q4 | 49 Thousand USD | -19.67% |
2016 Q3 | 61 Thousand USD | -1.61% |
2016 Q2 | 62 Thousand USD | 8.77% |
2015 FY | 147 Thousand USD | -27.59% |
2015 Q1 | 29 Thousand USD | -44.23% |
2015 Q2 | 39 Thousand USD | 34.48% |
2015 Q3 | 40 Thousand USD | 2.56% |
2015 Q4 | 39 Thousand USD | -2.5% |
2014 Q4 | 52 Thousand USD | 108.0% |
2014 FY | 203 Thousand USD | -3.79% |
2014 Q1 | 62 Thousand USD | 675.0% |
2014 Q2 | 64 Thousand USD | 3.23% |
2014 Q3 | 25 Thousand USD | -60.94% |
2013 Q4 | 8000.00 USD | -33.33% |
2013 Q3 | 12 Thousand USD | 0.0% |
2013 FY | 211 Thousand USD | 27.11% |
2013 Q1 | 34 Thousand USD | -40.35% |
2012 FY | 166 Thousand USD | 76.6% |
2012 Q4 | 57 Thousand USD | 29.55% |
2012 Q3 | 44 Thousand USD | 0.0% |
2011 FY | 94 Thousand USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Accelerate Diagnostics, Inc. | 12.05 Million USD | 81.068% |
BrainsWay Ltd. | 31.78 Million USD | 92.817% |
Cerus Corporation | 156.36 Million USD | 98.54% |
Envoy Medical, Inc. | 316 Thousand USD | -622.468% |
electroCore, Inc. | 16.03 Million USD | 85.758% |
Helius Medical Technologies, Inc. | 644 Thousand USD | -254.503% |
IceCure Medical Ltd | 3.22 Million USD | 29.297% |
Inogen, Inc. | 315.66 Million USD | 99.277% |
OrthoPediatrics Corp. | 148.73 Million USD | 98.465% |
Lucid Diagnostics Inc. | 2.42 Million USD | 5.972% |
Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -525.481% |
MaxCyte, Inc. | 41.28 Million USD | 94.471% |
NeuroOne Medical Technologies Corporation | 1.95 Million USD | -16.931% |
Nexalin Technology, Inc. | 110.74 Thousand USD | -1961.437% |
Orthofix Medical Inc. | 746.64 Million USD | 99.694% |
PAVmed Inc | 2.45 Million USD | 6.892% |
Rapid Micro Biosystems, Inc. | 22.51 Million USD | 89.862% |
RxSight, Inc. | 89.07 Million USD | 97.437% |
Sight Sciences, Inc. | 81.05 Million USD | 97.183% |
SI-BONE, Inc. | 138.88 Million USD | 98.356% |
TELA Bio, Inc. | 58.45 Million USD | 96.094% |
Treace Medical Concepts, Inc. | 187.11 Million USD | 98.78% |
Vivos Therapeutics, Inc. | 13.8 Million USD | 83.458% |
Acutus Medical, Inc. | 7.16 Million USD | 68.132% |
Talis Biomedical Corporation | 412 Thousand USD | -454.126% |
Spectral AI, Inc. | 18.05 Million USD | 87.356% |
Nano-X Imaging Ltd. | 9.9 Million USD | 76.951% |
CVRx, Inc. | 39.29 Million USD | 94.19% |
DIH Holding US, Inc. Warrants | - USD | -Infinity% |
PetVivo Holdings, Inc. | 968.7 Thousand USD | -135.675% |
Bioventus Inc. | 512.34 Million USD | 99.554% |
Venus Concept Inc. | 76.35 Million USD | 97.01% |
TriSalus Life Sciences, Inc. | 18.51 Million USD | 87.667% |
LivaNova PLC | 1.15 Billion USD | 99.802% |
908 Devices Inc. | 50.22 Million USD | 95.455% |
Alphatec Holdings, Inc. | 482.26 Million USD | 99.527% |
Nemaura Medical Inc. | 77.04 Thousand USD | -2863.242% |
NeuroPace, Inc. | 65.42 Million USD | 96.51% |
LENSAR, Inc. | 42.16 Million USD | 94.585% |
Apyx Medical Corporation | 52.34 Million USD | 95.639% |
Cutera, Inc. | 212.36 Million USD | 98.925% |
STRATA Skin Sciences, Inc. | 33.35 Million USD | 93.156% |
BioSig Technologies, Inc. | 18 Thousand USD | -12583.333% |
Anika Therapeutics, Inc. | 166.66 Million USD | 98.63% |
ClearPoint Neuro, Inc. | 23.95 Million USD | 90.47% |
Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 99.852% |
Axonics, Inc. | 366.37 Million USD | 99.377% |
Outset Medical, Inc. | 130.37 Million USD | 98.249% |
IRIDEX Corporation | 51.86 Million USD | 95.599% |
PROCEPT BioRobotics Corporation | 136.19 Million USD | 98.324% |
IRadimed Corporation | 65.56 Million USD | 96.518% |
Tivic Health Systems, Inc. | 1.17 Million USD | -94.133% |
INVO Bioscience, Inc. | 3.02 Million USD | 24.418% |
Telesis Bio, Inc. | 27.5 Million USD | 91.701% |
Viemed Healthcare, Inc. | 183 Million USD | 98.753% |
Varex Imaging Corporation | 811 Million USD | 99.718% |
Quipt Home Medical Corp. | 221.74 Million USD | 98.97% |
Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
Pulmonx Corporation | 68.67 Million USD | 96.676% |
Dynatronics Corporation | 32.53 Million USD | 92.983% |
Modular Medical, Inc. | - USD | -Infinity% |
ReShape Lifesciences Inc. | 8.67 Million USD | 73.692% |
Semler Scientific, Inc. | 68.18 Million USD | 96.652% |
InMode Ltd. | 492.04 Million USD | 99.536% |
Bruker Corporation | 2.96 Billion USD | 99.923% |
Cytosorbents Corporation | 36.34 Million USD | 93.719% |
DexCom, Inc. | 3.62 Billion USD | 99.937% |
Align Technology, Inc. | 3.86 Billion USD | 99.941% |
Viveve Medical, Inc. | 6.42 Million USD | 64.472% |
ZimVie Inc. | 457.43 Million USD | 99.501% |
Movano Inc. | - USD | -Infinity% |
Cytek Biosciences, Inc. | 193.01 Million USD | 98.817% |
Nexalin Technology, Inc. | 110.74 Thousand USD | -1961.437% |
DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
Tandem Diabetes Care, Inc. | 747.71 Million USD | 99.695% |
Profound Medical Corp. | 7.33 Million USD | 68.858% |
Insulet Corporation | 1.69 Billion USD | 99.865% |
enVVeno Medical Corporation | - USD | -Infinity% |
Surmodics, Inc. | 126.07 Million USD | 98.189% |
iCAD, Inc. | 17.31 Million USD | 86.817% |
Nuwellis, Inc. | 8.86 Million USD | 74.244% |
Biotricity, Inc. | 12.06 Million USD | 81.075% |
iRhythm Technologies, Inc. | 492.68 Million USD | 99.537% |
Aethlon Medical, Inc. | - USD | -Infinity% |
InspireMD, Inc. | 6.2 Million USD | 63.207% |
PAVmed Inc. | 2.45 Million USD | 6.892% |
BIOLASE, Inc. | 49.16 Million USD | 95.356% |
Beyond Air, Inc. | 1.15 Million USD | -96.98% |
FONAR Corporation | 102.88 Million USD | 97.781% |
AxoGen, Inc. | 159.01 Million USD | 98.564% |
Vivani Medical, Inc. | - USD | -Infinity% |
Tactile Systems Technology, Inc. | 274.42 Million USD | 99.168% |
Inari Medical, Inc. | 493.63 Million USD | 99.538% |
UFP Technologies, Inc. | 400.07 Million USD | 99.429% |
QT Imaging Holdings, Inc. | - USD | -Infinity% |
Heart Test Laboratories, Inc. | 18.6 Thousand USD | -12174.194% |
Tenon Medical, Inc. | 2.92 Million USD | 22.029% |
Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
Co-Diagnostics, Inc. | 6.81 Million USD | 66.486% |
AdaptHealth Corp. | 3.2 Billion USD | 99.929% |
Sintx Technologies, Inc. | 2.62 Million USD | 13.095% |
Quanterix Corporation | 122.36 Million USD | 98.134% |
Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
Sensus Healthcare, Inc. | 24.4 Million USD | 90.645% |
Pacific Biosciences of California, Inc. | 200.52 Million USD | 98.861% |
TransMedics Group, Inc. | 241.62 Million USD | 99.055% |
ReWalk Robotics Ltd. | 13.85 Million USD | 83.521% |
NeuroMetrix, Inc. | 5.9 Million USD | 61.314% |
Hyperfine, Inc. | 11.03 Million USD | 79.306% |
Establishment Labs Holdings Inc. | 165.15 Million USD | 98.618% |
Biomerica, Inc. | 5.41 Million USD | 57.839% |
Bone Biologics Corporation | - USD | -Infinity% |
AVITA Medical, Inc. | 50.56 Million USD | 95.485% |
Bluejay Diagnostics, Inc. | - USD | -Infinity% |
Silk Road Medical, Inc | 177.13 Million USD | 98.711% |